
TRANSOCEAN LTD
RIGNYSE🏆 #883 by market capEarnings Nov 4US Equity
$5.81▲ $0.09 (+1.57%)
Live1h—
24h▲ 1.6%
7d—
14d—
30d—
1y—
🏦Market Cap
$6.49B
Small Cap
📈Revenue Growth (YoY)
+8.5%
Slowing
📊Gross Margin
41.6%
Healthy
💵FCF Margin
22.0%
Strong
⚖️P/S Ratio
1.5x
Cheap
Otter Score
46
Weak
📊
Analyst Ratings
Price
$5.81
Total
64
Raised
17
Lowered
22
Avg PT
$7.00
| Institution | Action | Rating | Date |
|---|---|---|---|
Susquehanna | Reiterated | Positive | 2026-07-08 |
Barclays | Upgraded | Equal Weight → Overweight | 2026-05-07 |
TD Cowen | Reiterated | Hold | 2026-05-06 |
Morgan Stanley | Reiterated | Equal Weight | 2026-04-15 |
BTIG | Reiterated | Buy | 2026-02-09 |
Citigroup | Reiterated | Neutral | 2025-12-11 |
JP Morgan | Downgraded | Neutral → Underweight | 2025-12-10 |
Evercore ISI Group | Downgraded | Outperform → In Line | 2025-01-15 |
Benchmark | Downgraded | Buy → Hold | 2024-10-15 |
B of A Securities | Reiterated | Underperform | 2024-04-15 |
Piper Sandler | Reiterated | Neutral | 2024-03-11 |
Clarkson Capital Markets | Upgraded | Neutral → Buy | 2023-03-22 |
Capital One | Upgraded | Equal Weight → Overweight | 2022-08-02 |
Clarksons Platou | Downgraded | Buy → Neutral | 2020-06-15 |
Credit Suisse | Reiterated | Neutral | 2020-05-01 |
RBC Capital | Downgraded | Sector Perform → Underperform | 2020-04-22 |
RF Lafferty | Reiterated | Buy | 2020-03-27 |
Wells Fargo | Downgraded | Overweight → Equal Weight | 2020-03-13 |
Argus Research | Downgraded | Hold → Sell | 2020-02-19 |
Bernstein | Reiterated | Underperform | 2020-01-14 |
Deutsche Bank | Reiterated | Sell | 2019-11-20 |
Citi | Downgraded | Buy → Neutral | 2019-06-14 |
Goldman Sachs | Reiterated | Buy | 2019-03-11 |
DNB Markets | Upgraded | Hold → Buy | 2019-01-09 |
Fearnleys | Reiterated | Buy | 2018-10-18 |
BTIG Research | Reiterated | Buy | 2018-09-18 |
Bank of America | Reiterated | Neutral | 2018-04-18 |
HSBC | Upgraded | Hold → Buy | 2018-04-04 |
Jefferies | Upgraded | Hold → Buy | 2018-01-04 |
UBS | Upgraded | Neutral → Buy | 2017-09-25 |
Pareto Securities | Upgraded | Hold → Buy | 2017-08-18 |
Pareto | Upgraded | Hold → Buy | 2017-08-18 |
Nomura | Reiterated | Reduce | 2017-08-17 |
Odeon Capital | Reiterated | Sell | 2017-05-17 |
PiperJaffray | Upgraded | Underweight → Neutral | 2017-01-25 |
Arctic Securities | Reiterated | Buy | 2017-01-05 |
Canaccord Genuity | Upgraded | Hold → Buy | 2016-11-03 |
Scotiabank | Upgraded | Sector Perform → Sector Outperform | 2016-10-04 |
Scotia Howard Weil | Upgraded | Sector Perform → Sector Outperform | 2016-10-04 |
Seaport Global | Upgraded | Reduce → Neutral | 2016-05-13 |
IBERIA Capital Partners | Reiterated | Sector Perform | 2016-02-26 |
iBERIA Capital Partners | Reiterated | Sector Perform | 2016-02-26 |
KLR Group | Reiterated | Buy | 2015-12-14 |
Guggenheim | Upgraded | Neutral → Buy | 2015-11-30 |
Edward Jones | Downgraded | Hold → Sell | 2015-04-22 |
BMO Capital | Reiterated | Underperform | 2015-02-18 |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2014-10-17 |
Simmons & Co. | Downgraded | Neutral → Underweight | 2014-01-29 |
Nordea | Downgraded | Hold → Sell | 2014-01-23 |
Nordea Equity | Downgraded | Hold → Sell | 2014-01-22 |
ISI Group | Downgraded | Cautious → Sell | 2014-01-13 |
Capital One Financial | Downgraded | Buy → Neutral | 2013-11-26 |
Wunderlich Securities | Reiterated | Hold | 2013-11-19 |
Wunderlich | Reiterated | Hold | 2013-11-19 |
Mainfirst | Upgraded | Underperform → Outperform | 2013-11-08 |
MainFirst Bank AG | Upgraded | Underperform → Outperform | 2013-11-08 |
Argus Capital | Downgraded | Buy → Hold | 2013-10-15 |
Swedbank | Downgraded | Buy → Neutral | 2013-09-20 |
Johnson Rice | Downgraded | Overweight → Underweight | 2013-08-16 |
Global Hunter Securities | Downgraded | Buy → Neutral | 2013-08-09 |
Macquarie | Downgraded | Outperform → Neutral | 2013-02-26 |
Dahlman Rose | Reiterated | Buy | 2012-11-07 |
Oracle Investment Research | Downgraded | Strong Buy → Buy | 2012-09-27 |
Tudor Pickering | Downgraded | Accumulate → Hold | 2012-08-03 |
One row per institution, most recent rating